Among the large set of cell surface glycan structures, the carbohydrate polymer polysialic acid (polySia) plays an important role in vertebrate brain development and synaptic plasticity. The main carrier of polySia in the nervous system is the neural cell adhesion molecule NCAM. As polySia with chain lengths of more than 40 sialic acid residues was still observed in brain of newborn Ncam −/− mice, we performed a glycoproteomics approach to identify the underlying protein scaffolds. Affinity purification of polysialylated molecules from Ncam −/− brain followed by peptide mass fingerprinting led to the identification of the synaptic cell adhesion molecule Syn-CAM 1 as a so far unknown polySia carrier. SynCAM 1 belongs to the Ig superfamily and is a powerful inducer of synapse formation. Importantly, the appearance of polysialylated SynCAM 1 was not restricted to the Ncam −/− background but was found to the same extent in perinatal brain of WT mice. PolySia was located on Nglycans of the first Ig domain, which is known to be involved in homo-and heterophilic SynCAM 1 interactions. Both polysialyltransferases, ST8SiaII and ST8SiaIV, were able to polysialylate SynCAM 1 in vitro, and polysialylation of SynCAM 1 completely abolished homophilic binding. Analysis of serial sections of perinatal Ncam −/− brain revealed that polySia-SynCAM 1 is expressed exclusively by NG2 cells, a multifunctional glia population that can receive glutamatergic input via unique neuron-NG2 cell synapses. Our findings suggest that polySia may act as a dynamic modulator of SynCAM 1 functions during integration of NG2 cells into neural networks.
polysialic acid | NG2 cells | glycosylation | polysialyltransferases | glycoproteomics G lycosylation represents the most complex posttranslational modification, with an overwhelming diversity of oligosaccharide structures. Moreover, a single protein can be variably glycosylated giving rise to multiple glycoforms with distinct biological functions. Unraveling the impact of glycosylation on the structure and function of proteins is therefore often an arduous task. A striking example for the capability of an individual glycan structure to induce dramatic functional changes on the underlying protein is polysialic acid (polySia). In vertebrates, this linear α2,8-linked homopolymer of 5-N-acetylneuraminic acid (Neu5Ac) was first described as a developmentally regulated modification of the neural cell adhesion molecule (NCAM) (1) (2) (3) . Polysialylation disrupts the adhesive properties of NCAM and appearance of the bulky polyanionic glycan on the cell surface generally increases the intercellular space (4, 5) . Thus, polySia is a modulator of cell interactions involved in dynamic processes such as neural cell migration, neurite outgrowth, neural path finding, and synaptic plasticity (6) (7) (8) (9) . Although it is abundantly expressed during embryonic and early postnatal brain development, polySia is restricted to areas with ongoing neurogenesis and synaptic plasticity in adult brain (10) (11) (12) .
In mammals, polysialylation is catalyzed by the Golgi-resident polysialyltransferases (polySTs) ST8SiaII and ST8SiaIV, and simultaneous ablation of both enzymes leads to a complete loss of polySia (13, 14) . In contrast to Ncam −/− mice, which still contain residual amounts of polySia and manifest only a mild phenotype (15) , St8sia2 −/− St8sia4 −/− double KO mice are characterized by postnatal lethality and severe malformations of major axon tracts (14, 16, 17) . Lethality and brain wiring defects could be attributed to erroneous exposure of polySia-free NCAM (14, 18) , highlighting the crucial role of polySia in masking the underlying protein and thereby preventing improper interactions.
Although NCAM is by far the most abundant polySia carrier in mammals, context-dependent polysialylation of a restricted set of other glycoproteins has been described. These are CD36 in human milk, the α-subunit of a voltage-gated sodium channel in adult rat brain, and neuropilin-2 in mature human dendritic cells (19) (20) (21) . Based on the observation that Ncam −/− brains still contain low but clearly detectable amounts of polySia (ref. 15 and the present study), we performed a glycoproteomic approach to screen for respective polySia carriers. This led to the identification of the synaptic cell adhesion molecule SynCAM 1 as a target for polysialylation. SynCAM 1 is a member of the Ig superfamily composed of three Ig modules comprising six potential Nglycosylation sites, a variable stem region with several putative Oglycosylation sites, a single transmembrane domain, and a short carboxyl-terminal intracellular tail (22) . Because of its identification in different tissues, SynCAM 1 (official gene name Cadm1) has various names: nectin-like protein 2 (Necl-2) (23), tumor suppressor in lung cancer 1 (TSLC-1) (24), spermatogenic Ig superfamily molecule (SgIGSF) (25) , Ig superfamily 4 (IgSF4) (26) , and RA175 (27) . SynCAM 1 contributes to a variety of intercellular junctions by mediating Ca 2+ -independent cell adhesion through homo-and heterophilic interactions (22, 23, (28) (29) (30) . In the brain, SynCAM 1 localizes to synapses, bridges the synaptic cleft by homo-and heterophilic transinteraction with SynCAM 2, and acts as a potent inducer of synapse formation (22, 31 ). Here we demonstrate that, in vivo, a subfraction of SynCAM 1 is selectively polysialylated at the third N-glycosylation site and expressed by a subset of NG2 cells. In vitro polysialylation by either ST8SiaII or ST8SiaIV completely abolished homophilic SynCAM 1 binding, implying that polysialylation affects SynCAM 1 functions and may serve as a crucial modulator of SynCAM 1 interactions during integration of NG2 glia into neural networks. (15) . To analyze residual polySia, i.e., polymer length and total amounts in more detail, we applied the 1,2-diamino-4,5-methylenedioxybenzene (DMB)-HPLC method (13, 32, 33) to whole brain lysates of newborn Ncam −/− animals. Released polySia chains were fluorescently labeled and separated according to the degree of polymerization by anion exchange chromatography. Although the amount of all polymer species was drastically reduced compared with WT samples, polySia with more than 40 residues was still detectable in NCAM-deficient brain ( Fig. 1 A and B) . Quantification revealed that brain of Ncam −/− mice contained only 3.5% of the WT polySia level (Fig. 1C) . Taking into account that visualization of long polySia chains strongly depends on the amount of material applied (34) , one might assume that polySia synthesized in Ncam −/− and WT brain reaches similar chain lengths.
Results

Characterization of PolySia in Perinatal Brain of Ncam
Identification of SynCAM 1 as PolySia Carrier in Developing Mouse
Brain. Polysialylated protein(s) in whole brain lysates of newborn Ncam −/− mice were characterized by Western blotting applying the tenfold amount of lysate compared with WT samples to compensate for the low polySia level. In WT samples, immunostaining with the polySia-specific mAb 735 revealed the typical broad polySia-NCAM signal at approximately 250 kDa, which was completely abolished after treatment with polySia-specific endosialidase N (endoN; Fig. 2A ). Reprobing with anti-NCAM mAb H28 displayed a similar high molecular weight band which, after endoN treatment, gave rise to two focused bands representing the NCAM isoforms NCAM-140 and -180. In contrast, the main endoN sensitive signal observed with mAb 735 in lysate of Ncam −/− brain centered at approximately 110 kDa and no signal was obtained with mAb H28. To identify the underlying protein scaffold, polysialylated molecules were isolated from Ncam −/− brain extracts by affinity chromatography using mAb 735. After separation by SDS/PAGE, a gel slice spanning the molecular mass range of 100 to 150 kDa was used for tryptic in-gel digest. Analysis of the resulting peptides by peptide mass fingerprinting and mass spectrometric fragmentation analysis resulted in the identification of SynCAM 1 with significant probability scores of 78 and 186 (P < 0.05), respectively (Fig. S1 ). To verify this result, polysialylated proteins were affinity-isolated from Ncam −/− brain extracts and characterized by Western blotting with an anti-SynCAM 1 antibody. As shown in Fig. 2B , a broad band with an apparent molecular mass of 100 to 120 kDa was observed. After endoN digest, the signal broadened and bands with apparent molecular masses ranging from 85 kDa to 110 kDa could be distinguished. The fact that no discrete bands were formed is most likely because of the ) mice (postnatal day 1) were directly derivatized with the fluorescence dye DMB and separated on an anion exchange column according to the number of sialic acid residues. In each case, 9% of the total brain homogenate (equivalent to 7 mg of original brain tissue) was injected. To determine the maximally detectable chain length, respective profiles were also generated with 86% aliquots (equivalent to 69 mg of brain tissue; Insets). The number of sialic acid residues is given for selected peaks on top of the profiles. described heterogeneous glycosylation of SynCAM 1 by N-and O-glycans and/or the presence of different isoforms (35, 36) . In a second experiment, SynCAM 1 immunoprecipitated with an anti-SynCAM 1 antibody was analyzed by immunoblotting with mAb 735 (Fig. 2C) . Again, a polySia-signal in the molecular mass range of 100 to 150 kDa was observed, which was not detected after endoN pretreatment. The amount of total SynCAM 1 in perinatal Ncam −/− brain decreased only slightly after complete removal of the polySia-SynCAM 1 fraction by immunoprecipitation with mAb 735 (Fig. S2A) . Thus, only a subfraction of SynCAM 1 is modified by polySia. Further analysis of the polySia-SynCAM 1 levels at postnatal d 2, d 21, and adult stage demonstrated a drastic decrease of polySia-SynCAM 1 during postnatal development, whereas no obvious change in the level of total SynCAM 1 was detected (Fig. S3) .
Although our results clearly identified SynCAM 1 as a target for polysialylation in Ncam −/− mice, the question remained whether this is a compensatory response to the lack of NCAM. Consequently, polysialylation of SynCAM 1 was studied in perinatal brain of WT mice using 10 times the amount of brain extracts compared with Fig. 1A (Fig. S2B) . Under these conditions, the polySia signal covered not only the dominating high molecular mass band of polySia-NCAM but also the mass range around 110 kDa, where polySia-SynCAM 1 migrates. To prove the presence of polysialylated SynCAM 1 in WT brain, immunoprecipitates obtained with an anti-SynCAM 1 antibody were stained with mAb 735 (Fig. 2C) . In both WT and Ncam −/− brain, comparable amounts of polySia-SynCAM 1 were detected. Together these data demonstrate that SynCAM 1 is an NCAM-independent polySia carrier. (Fig. 3B ) revealed that removal of N-glycans from polySia-SynCAM 1 resulted in two prominent bands. The molecular masses of approximately 48 and 65 kDa match with the masses described for unglycosylated and O-glycosylated SynCAM 1 variants, respectively (22, 35, 36) .
For allocation of the polySia chains to distinct N-glycosylation sites, the total fraction of polysialylated glycopeptides was immunoaffinity-isolated from whole brain homogenates and analyzed by MALDI-TOF MS. After de-N-glycosylation by PNGaseF, only one additional signal at m/z 1377.7 was detected (Fig.  3C) , corresponding to the deglycosylated tryptic SynCAM 1 peptide comprising the third N-glycosylation site (Asn 116 ) in which the glycosylated Asn has been converted to Asp as a result of PNGaseF action. Tandem MALDI-TOF MS analysis verified the sequence of this peptide as V 112 SLTDVSISDEGR 124 (Fig.  3D ), demonstrating that SynCAM 1 is polysialylated on N-glycans at Asn 116 . Thus, within the limit of detection, the presence of other proteins carrying polySia on N-glycans can be ruled out. A corresponding Protein A-NCAM chimera was used as positive control, and reaction products were analyzed before and after treatment with endoN. As shown in Fig. 4A , both ST8SiaII and ST8SiaIV were able to polysialylate SynCAM 1 as demonstrated by the appearance of radiolabeled protein that migrated significantly more slowly than the same protein after endoN treatment. To prove that polySia was added to SynCAM 1, reaction products obtained after polysialylation with nonradiolabeled substrate were analyzed by Western blotting with anti-SynCAM 1 antibody (Fig. 4B ). Before polysialylation, soluble SynCAM 1 migrated with an apparent molecular mass of approximately 55 kDa (Fig. 4B Left) , whereas after incubation with either ST8SiaII or ST8SiaIV, a broad smear ranging from 55 to 250 kDa appeared. This smear was sensitive to endoN, confirming that polySia was added to SynCAM 1. Notably, SynCAM 1 expressed in CHO-6B2 cells was not used as an acceptor molecule (Fig. 4B Right) . Because of a lack of a functional CMP-sialic acid transporter, CHO-6B2 cells express exclusively asialo-glycoconjugates (37) . Thus, the presence of terminally monosialylated glycans is a prerequisite for both ST8SiaII and ST8SiaIV to polysialylate SynCAM 1.
Homophilic SynCAM 1 Binding Is Abrogated by Polysialylation. To study the impact of polysialylation on SynCAM 1-mediated interactions, we monitored the effect of this modification on homophilic SynCAM 1 binding. An Fc-chimera of the extracellular part of SynCAM 1 fused to the Fc region of human IgG was expressed in CHO-2A10 cells and isolated by affinity chromatography on protein G-Sepharose. Fluorophore-labeled beads were coated with purified SynCAM 1-Fc and bead aggregation was monitored before and after in vitro polysialylation (Fig. 4C ). Extensive aggregation, leading to large bead clusters, was observed for the nonpolysialylated form of SynCAM 1. However, after in vitro polysialylation of SynCAM 1 by either ST8SiaII or ST8SiaIV, aggregation was abrogated and only monodisperse beads were visible. Subsequent removal of polySia by endoN restored Syn-CAM 1 binding, and reaggregation of the beads to large clusters was observed. Thus, polysialylation of SynCAM 1 inhibits homophilic binding in vitro, strongly indicating a functional role in modulating SynCAM 1 interactions in vivo (Fig. 4D ).
PolySia-SynCAM 1 Is Expressed on NG2 Cells. Analysis of serial brain sections obtained from newborn Ncam −/− mice revealed that polySia-positive cells were scattered throughout the gray matter but scarcely found in the white matter such as corpus callosum. PolySia staining was particularly abundant in the pontomedullary hindbrain and completely absent in brain sections of Ncam
St8sia4
−/− triple KO mice (Fig. 5A ). PolySia colocalized with SynCAM 1 and was restricted to a subpopulation of cells that are positive for the proteoglycan NG2 (Fig. 5 B and C and Fig. S4 ), a marker protein characteristic for a distinct type of glia cells. As NG2-negative cells that are wrapped by NG2-positive processes can be mistaken for NG2-positive cells, we confirmed our results by analyzing single cells in primary cultures from basal hindbrain of newborn Ncam −/− mice. Again, polySia was found colocalized with SynCAM 1 and associated with cells positive for NG2 and Olig2, a transcription factor frequently used as a second marker for NG2 cells (38) (Fig. S5) . Consistent with described characteristics of NG2 cells (39) , polySia-SynCAM 1-positive cells were negative for glial fibrillary acidic protein, β-IIItubulin, and microtubule-associated protein 2 (Figs. S4 and S5) .
Discussion
In the present study, we show that the synaptic cell adhesion molecule SynCAM 1 is a target for polysialylation in developing mouse brain. In vivo, polySia is selectively added to N-glycans at the third N-glycosylation site located within the first Ig domain, which is involved in homo-and heterophilic SynCAM 1 interactions (36) . Addition of the bulky polyanionic carbohydrate polymer completely blocked homophilic binding in vitro. Although we cannot exclude differences in the extend of polysialylation under in vitro and in vivo conditions, this finding implicates that polySia serves as a potent regulator of SynCAM 1 interactions in vivo as it is known for NCAM (6) . Compared with NCAM, which is composed of five Ig and two fibronectin type III modules, Syn-CAM 1 contains only three Ig-like domains. Both molecules comprise six N-glycosylation sites but only particular sites are used for polysialylation in vivo. Intriguingly, the polySia acceptor sites of both NCAM and SynCAM 1 are located in an Ig domain that is two domains apart from the membrane (Fig. S7) . As polySTs are also transmembrane proteins, proper spacing might determine accessibility and in vivo selectivity for particular N-glycosylation sites as indicated by loss of site specificity in N-glycosylation mutants if both enzyme and acceptor molecule lack their transmembrane domain (Fig. S7) .
In the perinatal brain, polySia-SynCAM 1 was found exclusively on a subset of NG2 cells. These glia cells (also known as polydendrocytes or synantocytes) are distinct from mature oligodendrocytes, astrocytes, and microglia, and make up 5% to 10% of all glia in the developing and mature CNS (39) (40) (41) . They are scattered throughout the developing and adult brain and are considered as multipotential progenitor pool that can give rise to oligodendrocytes, astrocytes, and neurons. Remarkably, a subset of NG2 cells can promote presynaptic specialization in neurons, leading to unique synaptic association between NG2 cells and neurons (39, 41) . SynCAM 1 is known as a powerful inducer of synaptic differentiation. When coexpressed with glutamate receptors in nonneuronal cells, SynCAM 1 is sufficient to induce artificial synapses with cocultured neurons (22) . To date, little is known what drives the assembly of neuron-NG2 cell synapses. To our knowledge, this is the first report of SynCAM 1 expression on NG2 cells, suggesting that this cell adhesion molecule could play a role in inducing this specialized neuron-glia synapse. By attenuating SynCAM 1-mediated functions, polysialylation of SynCAM 1 may have an important regulatory role in the formation of neuron-NG2 cell interactions. Moreover, polySia-SynCAM 1 has the potential to regulate the communication between NG2 cells and neurons, as it is known that polySia directly increases the probability of the open state of AMPA-type glutamate receptors (42), the receptor type through which NG2 cells receive synaptic inputs (43, 44) .
Remarkably, only a subfraction of SynCAM 1 is polysialylated in perinatal brain. In contrast, at this developmental stage when both polySTs reach peak level and almost ubiquitous expression, NCAM is quantitatively converted to its polysialylated form (13, 45) . As SynCAM 1 is broadly expressed in all brain regions perinatally, polysialylation might be restricted to particular glyco-and/ or isoforms of SynCAM 1. Alternative splicing of three variable exons can theoretically give rise to eight transmembrane isoforms that differ only in the region between Ig3 and the transmembrane domain. The variably spliced peptides contain two to 17 putative O-glycosylation sites, leading to multiple glycoforms (35) . In vitro, both polySTs were able to polysialylate soluble SynCAM 1 lacking the variable stem region, demonstrating that Ig1-3 modules are sufficient to mediate interaction with polySTs. However, it is still possible that, in vivo, only particular isoforms allow proper spacing and accessibility of the N-glycan acceptor site.
In summary, we characterized SynCAM 1 as a polySia acceptor in the developing brain and demonstrated that polySiaSynCAM 1 is restricted to a subpopulation of NG2 cells. NG2 cells form functional synapses in the postnatal brain and serve as the primary source of myelinating oligodendrocytes during development and myelin repair. Future experiments will be needed to determine the exact role of polySia-SynCAM 1 for NG2 cell functions.
Materials and Methods
Please refer to the SI Materials and Methods for details on mice, antibodies, and further methods.
Identification of SynCAM 1 as Polysialylated Glycoprotein and Intramolecular
Localization of PolySia. Isolation of polysialylated proteins, isolation and deglycosylation of polySia-glycopeptides, immunoblot, and DMB-HPLC analysis were carried out as previously described (13, 33, 45) . PolySia-SynCAM 1 was identified by in-gel tryptic digest, peptide mass fingerprint analysis using MALDI-TOF MS, MS fragmentation analysis, and database search. Isolated polySia-glycopeptides were chemically desialylated, treated with PNGase F and analyzed by tandem MALDI-TOF MS.
In Vitro Polysialylation and Bead Aggregation Assay. SynCAM 1 lacking transmembrane domain and variably spliced stem region was produced in CHO cells either as a Protein A-SynCAM 1 chimera or C-terminally tagged with a Myc-epitope. After immunoadsorption to either IgG-or Protein GSepharose coupled with anti-Myc mAb 9E10, in vitro polysialylation was performed as described previously (46) with purified soluble ST8SiaII and ST8SiaIV. Homophilic SynCAM 1 binding was analyzed in a bead aggregation assay with purified SynCAM 1 fused to the Fc-part of human IgG1 (36) .
Immunohistochemistry. Dissection of brains from transcardially perfused mice, preparation of paraffin sections, immunofluorescence staining and microscopy were performed as described (13, 47) .
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Isolation of Polysialylated Proteins from Mouse Brain Extracts.
Postnatal d 1 brains of NCAM KO mice were homogenized in 20 mM Tris/HCl buffer, pH 8.0, containing 5 mM EDTA, 150 mM NaCl, 1% (vol/vol) Triton X-100, 200 U/mL aprotinin, 1 mM phenylmethylsulfonylfluoride, and 20 μg/mL leupeptin (1 mL per brain) (3). The lysate was shaken overnight at 4°C and, after centrifugation, supernatants were mixed with mAb 735-conjugated protein A magnetic beads (500 μL beads/14 mL lysate). The beads were washed 10 times each with 10 mL of washing buffer 1a [20 mM Tris/HCl, pH 8.0, 200 mM NaCl, 0.5% (vol/vol) Triton X-100] and washing buffer 2a (20 mM Tris/ HCl, pH 8.0, 150 mM NaCl). Polysialylated proteins were eluted using 100 mM triethylamine buffer, pH 11.5, and lyophilized. Immunopurification using polyclonal anti-SynCAM 1 antibody was performed in an analogous manner.
SDS/PAGE and Western Blotting. Brain lysates as well as purified proteins were resolved by 10% SDS/PAGE under reducing conditions (6) . For digestion of polySia chains proteins were treated with endoN (2 ng/μL overnight at 8°C). Release of Nglycans by PNGaseF was performed as previously described for polysialylated proteins (7) . Proteins were transferred to polyvinylidene difluoride membrane (GE Healthcare), probed with 5 μg/mL anti-polySia mAb 735, anti-NCAM mAb H28, antiSynCAM 1 mAb 3E1, or anti-SynCAM 1 pAb and detected by enhanced chemiluminescence (Pierce).
In-Gel Digest for Peptide Mass Fingerprint Analysis. For the in-gel digest, commercially available gels were used (10%; BioRad). The tryptic digest was performed as described previously (8) with adaptation for membrane proteins and the size of the gel section. Briefly, respective gel slices were transferred with 100 μL H 2 O into a LoBind tube (Eppendorf) and washed for 15 min under shaking with 100 μL 50 mM ammonium bicarbonate, pH 8.5, containing 50% (vol/vol) acetonitrile. After removal of the solvent, the gel was dried and 100 μL acetonitrile were added. The washing procedure was repeated twice with 100 μL 50 mM ammonium bicarbonate, pH 8.5, respectively, and the gel piece was dried in a vacuum centrifuge. After reduction and carbamidomethylation trypsin (sequencing grade; Promega), diluted in protease max enhancer (Promega) to a final concentration of 10 ng/μL, was added and incubated for 1 h at 37°C. Peptides were extracted by sonification with 100 μL 0.1% trifluoroacetic acid for 15 min and desalted using C-18 OMIX-Tips (Varian).
Isolation and Deglycosylation of PolySia-Glycopeptides. Four mouse brains were suspended in 2 mL lysis buffer (20 mM ammonium bicarbonate, pH 8.5, 6 M urea) and carbamidomethylated with iodacetamide. The lysate was diluted to 12 mL with 20 mM ammonium bicarbonate and digested with 100 μg trypsin (sequencing grade; Promega) overnight at 37°C. Trypsin was inactivated with 10 mM phenylmethylsulfonylfluoride. Resulting peptides were desalted on a P4-Biogel column (1 × 100 cm; BioRad). Desalted (glyco-)peptides were added to 50 μL mAb 735 magnetic beads as described earlier and the beads were washed with washing buffer 1b [20 mM ammonium bicarbonate, pH 8.5, 200 mM NaCl, 0.5% (vol/vol) Triton X-100] and 2b (20 mM ammonium bicarbonate, pH 8.5). PolySia peptides were eluted using 100 mM triethylamine buffer, pH 11.5, and lyophilized. PolySia-glycopeptides were desialylated by mild acid hydrolysis in 200 μL 1 M acetic acid at 80°C for 30 min before deglycosylation using PNGaseF as described earlier. Deglycosylated glycopeptides were desalted using C-18 OMIX-Tip (Varian).
DMB-HPLC Analysis.
To analyze the chain length and the amount of polySia, brains of 1-d-old mice were homogenized and delipidated as described previously (9, 10) . The dried tissue was dissolved in 300 μL DMB reaction buffer and incubated for 24 h at 4°C with shaking. The reaction was stopped by adding 70 μL of 1 M NaOH and insoluble material was removed by centrifugation. For separation of polySia chains, an LKB HPLC system was used, equipped with a DNAPac PA-100 column and a fluorescent detector set at 372 nm for excitation and 456 nm for emission. MilliQ water and 4 M ammonium acetate (E2) were used as eluents as described by Nakata et al. (11) . Elution was performed by the following gradient: T 0min = 0% (vol/vol) E2; T 15min = 8% (vol/vol) E2; T 40min = 12% (vol/vol) E2; and T 160min = 23% (vol/vol) E2. The column was washed with 100% (vol/vol) E2 for 10 min. Aliquots corresponding to 9% or 86% of the supernatants were injected for quantification of the peak or for determination of the maximal detectable chain length, respectively.
MALDI-TOF MS/MS Analysis. MALDI-TOF MS analyses were performed on an Ultraflex TOF mass spectrometer (Bruker-Daltonik) equipped with a nitrogen laser and a LIFT-MS/MS facility and controlled by FlexControl 3.0 software as described previously (3, 12) . The instrument was operated in positive-ion reflector mode. Desalted peptides (1 μL) of the in-gel digest were transferred onto prespotted anchorchip (PAC; Bruker-Daltonik) targets. After drying, the spot was washed with 10 μL 20 mM ammonium phosphate buffer containing 0.1% trifluoroacetic acid. Isolated polysialylated glycopeptides were loaded onto a stainless steel target in 1 μL water and mixed with 1 μL matrix (10 mg/mL 2,5-dihydroxybenzoic acid in 50% acetonitrile, 1% o-phosphoric acid) before and after deglycosylation with PNGaseF (13) . In general, 500 to 5,000 shots were accumulated in positive ion MS and MS/MS modes, respectively. External calibration of mass spectra was carried out using peptide calibration standard for MS (BrukerDaltonik). Masses were annotated and processed with FlexAnalysis 3.0. Annotation of fragment ions in the MS/MS mode was performed according to Medzihradszky (14) .
Database Search. For peptide mass fingerprinting scoring, the MALDI MS data were searched against the Mascot data search database using the Mascot program (http://www.matrixscience. com) with the following parameters: restriction to Mus musculus, peptide mass tolerance, 25 ppm; allow up to one missed cleavage; variable modifications considered were cysteine carbamidomethylation and methionine oxidation. For identification of the polysialylated N-glycosylation site, the peptide mass tolerance was constricted to 15 ppm and potential deamination of aspargine and glutamine was allowed as modification.
Plasmid Construction. To generate a SynCAM 1-Fc chimera, the region encoding the extracellular domains of SynCAM 1 (aa 1-346) was amplified by PCR with the primers MR74s (5′-GACTGC-TAGCATGGCGAGTGTAGTGCTG-3′) and MR75as (5′-GA-CTAGATCTACTTACCTGTATGATCCACTGCCCTGATC-3′) and full-length human SynCAM 1 cDNA (OriGene) lacking the variable spliced exons (accession no. NM_001098517) as template. The resulting PCR product was digested with NheI and BglII and ligated into the NheI/BamHI sites of pcDNA3.1-Ig upstream of the DNA sequence encoding the Fc part of human IgG1 (15) . The plasmid used for expression of soluble SynCAM 1 (aa 1-346) with a C-terminal Myc-epitope was generated by PCR with the primers MR72s (5′-GATCGGTACCGAATGGCGAGTGTAGTGCTG-3′) and MR73as (5′-GACTCTCGAGATGATCCACTGCCCTG-ATC-3′). After digestion with KpnI and XhoI, the obtained PCR product was ligated in the corresponding sites of pcDNA3.1-myc/ His (Invitrogen). The plasmid used for expression of a soluble Protein A-SynCAM 1 fusion protein comprising aa 39 to 346 of Syn-CAM 1 C-terminally fused to Protein A was generated by PCR using the primers MR58s (5′-GCATGAATTCGATCCCCACAGGTG-ATGGG-3′) and MR59as (5′-GCATGGTACCTTAATGATCC-ACTGCCCTGATCG-3′). The amplified PCR product was digested with EcoRI and KpnI and ligated into the corresponding sites of the vector pPROTA (16) . The plasmid encoding the Protein A-NCAM chimera was generated as described previously (17) . Full-length cDNAs of murine SynCAM 1, SynCAM 2, and Syn-CAM 3 were transcribed from 1 μg of total RNA of perinatal mouse brain using the SuperScript First-Strand Synthesis System (Invitrogen). SynCAM 1 cDNA was amplified by PCR with the primer pair MR68s (5′-GATCGGTACCATGGCGAGTGCTGTG-CTG-3′) and MR69as (5′-GCCATGCGGCCGCCTAGATGAA-GTACTCTTTCTTTTCTTCG-3). After digestion with KpnI and NotI, the obtained PCR product was ligated in the corresponding sites of pcDNA3.1-Zeo (Invitrogen). SynCAM 2 cDNA was amplified with the primer pair MR80s (5′-GATCGGATCCGCCAC-CATGATTTGGAAACGCAGCGC-3′) and MR81as (5′-GATC-GCGGCCGCTTAAATGAAATACTCTTTTTTCTC-3). The obtained PCR product was digested with BamHI and NotI and ligated in the corresponding sites of pcDNA3.1-Zeo (Invitrogen). SynCAM 3 cDNA was amplified with the primer pair MR83s (5′-GATC GATATCGCCACCATGGGGGCCCCTTCCGC-3′) and MR84as (5′-GATCGCGGCCGC CTAGATGAAATATTCCTT-CTTG-3′) and the resulting PCR product was digested with EcoRV and NotI and ligated into the corresponding sites of pcDNA3.1-Zeo. The identity of all constructs was confirmed by sequencing.
Cell Lines, Transfection, and Culture Conditions. CHO cells were maintained in DMEM/Ham F12 1:1 (Seromed) supplemented with 5% FCS and 1 mM sodium pyruvate in a 37°C, 5% CO 2 incubator. CHO-2A10 cells represent a genetic complementation group characterized by a deficient St8Sia4 gene rendering these cells polySia-negative (18, 19) . CHO-6B2 cells lack a functional CMP-sialic acid transporter and express exclusively asialo-glycoconjugates (20) . The murine fibroblast cell line LMTK − was maintained in DMEM (Seromed) supplemented with 10% FCS in a 37°C, 5% CO 2 incubator. Transient transfections were performed with Lipofectamine (Invitrogen) as described previously (21) . Spodoptera frugiperda (Sf9) cells (Gibco) were grown at 27°C in shaking culture at 75 rpm in protein-free Insect-Xpress medium (BioWhittaker/Lonza) and maintained at a density of 0.5 × 10 6 to 6 × 10 6 viable cells per mL. Transient expression of soluble polysialyltransferases was performed upon infection with recombinant baculovirus generated by the Bac-to-Bac System (Invitrogen).
In Vitro Polysialylation Assay. Soluble mouse ST8SiaII (residues 57-375) and hamster ST8SiaIV (residues 26-359) with an N-terminal hexa-histidine tag were secreted by Sf9 cells and purified by affinity chromatography on Ni 2+ -chelating columns (GE Healthcare). Soluble acceptor proteins were produced in CHO cells. Three days after transfection, cell culture supernatant of one 100-mm dish was harvested and concentrated 10-fold by ultrafiltration (Amicon Ultra-15, 10 kDa cut-off; Millipore). After preclearing with IgG-or Protein G-Sepharose (GE Healthcare), Protein A fusion proteins and SynCAM 1-Myc were isolated by immunoprecipitation with IgG-Sepharose and anti-Myc mAb 9E10 (Roche) covalently coupled to Protein G-Sepharose, respectively. Immunoprecipitates were washed twice with 1 mL of PBS solution (10 mM sodium phosphate, pH 7.4, 100 mM NaCl) and twice with reaction buffer (10 mM Mes, pH 6.7, 10 mM MnCl 2 ). In vitro polysialylation was performed in a final volume of 50 μL containing 2 μg of purified polysialyltransferase. For radioactive incorporation assays, 0.76 mM CMP-[ Bead Aggregation Assay. Homophilic SynCAM 1 binding was analyzed in a bead aggregation assay (22) using purified SynCAM 1-Fc bound to Protein A beads. Protein A (Sigma) was covalently coupled to green fluorescent FluoSpheres (1 μm diameter; Invitrogen) using 1-ethyl-1-3-(3-dimethylaminopropyl)-carbodiimide (Invitrogen) and beads (10 μL of a 2% suspension) were coated with 5 μg of purified SynCAM 1-Fc or human IgG Fc fragment (Jackson Immunoresearch). After washing three times with 1 mL of 0.5% BSA in PBS solution and twice with Mes buffer (10 mM Mes, pH 6.7, 10 mM MnCl 2 ), beads were incubated with 1 mM CMP-Neu5Ac (Nacalai Tesque) and 2 μg of recombinant soluble ST8SiaII or ST8SiaIV for 15 h at room temperature in a thermomixer (Eppendorf) at 1,350 rpm. For specific degradation of polySia, beads were washed twice with 0.5% BSA in PBS solution and incubated with 2.5 μg endoN for 30 min at 37°C. After washing three times with 0.5% BSA in PBS solution, beads were monodispersed by applying a 1-s ultrasound pulse in an ultrasonic bath (Sonorex Super; Bandelin) and loaded to chamber slides (μ-Slides; Ibidi). After incubation for 1.5 h at room temperature, beads were imaged under a fluorescence microscope (Axiovert 200 M; Zeiss).
Primary Cell Culture. Basal hindbrain of newborn Ncam −/− mice was dissected, transferred to 1× Hanks Balanced Salt Solution (Gibco), minced, and incubated with 10 mg/mL Trypsin type IX (Sigma) and 0.5 mg/mL DNase I (Roche) at 37°C for 10 min. During the second half of the incubation period, 0.5 mg/mL DNase I and 12 mM MgCl 2 were added. After gentle trituration, cells were collected by centrifugation (280 × g for 10 min at 4°C) and resuspended in DMEM (high glucose) containing 2 mM Glutamax, 1% (vol/vol) N2 supplement, 2% (vol/vol) B27 (all from Gibco), 10 μg/mL Insulin (Sigma), 10% (vol/vol) horse serum (Biochrom), and 5 μg/mL gentamycin (Gibco). Single cell suspensions were seeded at densities of 100,000 cells/cm 2 in 24-well plates containing glass coverslips coated with 100 μg/mL poly-D lysine (Sigma). After incubation for 48 h in a 37°C, 7.5% CO 2 incubator, cells were fixed for immunocytochemistry.
Immunocytochemistry. Cells were fixed with 4% paraformaldehyde for 30 min, permeabilized with 0.1% Triton X-100, blocked with 2% BSA for 1 h at room temperature, and incubated with primary antibodies for 2 h at room temperature. The following antibodies were used: polySia-specific mouse mAb 735 (10 μg/mL), antiSynCAM 1 IgY mAb 3E1 (5 μg/mL,), NG2 Proteoglycan-specific rabbit pAb (5 μg/mL), Olig2-specific rabbit pAb (1 μg/mL), β-IIItubulin-specific mouse mAb (5 μg/mL), SynCAM 2-specific rabbit pAb (5 μg/mL), and SynCAM 3-specific rabbit pAb (5 μg/m). Rabbit and mouse IgG-specific and IgY-specific Alexa 568-or Alexa 488-conjugated antibodies were used according to the manufacturer's recommendations. As first-layer control, cells were incubated in blocking solution lacking primary antibody. For double immunofluorescence staining, cross-reactivity of secondary antibodies was controlled by omitting either of the two primary antibodies. For negative controls, cells were pretreated with endosialidase (3 μg/mL in 0.1 M sodium phosphate, pH 7.4) for 1 h at 37°C before staining with mAb 735. Coverslips were mounted in Vectashield mounting medium containing DAPI (Vector Laboratories).
Immunohistochemistry. Whole brains of newborn Ncam −/− and Ncam −/− St8sia2 −/− St8sia4 −/− triple KO mice were dissected from animals transcardially perfused with 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, under anesthesia by hypothermia. After overnight postfixation, brains were embedded in a single paraffin block and cut into 3-to 4-μm serial sagittal sections. For immunofluorescence staining, sections were deparaffinzed, rehydrated, blocked for 1 h in PBS solution containing 10% BSA, 0.1% Triton X-100, and incubated with primary antibodies overnight at 4°C. The following antibodies were used: polySiaspecific mouse mAb 735 (10 μg/mL), anti-SynCAM 1 mAb 3E1 (2.5 μg/mL), NG2 Proteoglycan-specific rabbit pAb (5 μg/mL), GFAP-specific rabbit pAb (1:100), and MAP2-specific mouse mAb (2 μg/mL). Rabbit and mouse IgG-specific and IgY-specific Alexa 568-or Alexa 488-conjugated antibodies were used according to the manufacturer's recommendations. Antibody controls were performed as described for immunocytochemistry. Slides were mounted in Vectashield mounting medium containing DAPI (Vector Laboratories).
Microscopy. Microscopy was performed with a Zeiss Axiovert 200 M equipped with ApoTome module, AxioCam MRm digital camera, and AxioVison software (Zeiss). Low-magnification images were acquired using a ×20 Plan-Apochromat (0.8 NA). Nearconfocal optical sections of 0.81 μm thickness were obtained by ApoTome technology using a ×63 Plan-Apochromat oil immersion objective with 1.4 numerical aperture (Zeiss). Z stacks (3.5 μm) comprising sequential x-y sections were taken at 0.25-μm z intervals. Legend continued on following page 
